Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell profiling of human subventricular zone progenitors identifies SFRP1 as a target to re-activate progenitors. | Nat Commun | 2022 | 35210419 | PubTator, text mining | PubMed |
| Prokineticin-Receptor Network: Mechanisms of Regulation. | Life (Basel) | 2022 | 35207461 | PubTator, text mining | PubMed |
| Multielectrode Arrays for Functional Phenotyping of Neurons from Induced Pluripotent Stem Cell Models of Neurodevelopmental Disorders. | Biology (Basel) | 2022 | 35205182 | PubTator, text mining | PubMed |
| E3 Ubiquitin Ligase Regulators of Notch Receptor Endocytosis: From Flies to Humans. | Biomolecules | 2022 | 35204725 | PubTator, text mining | PubMed |
| Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases. | Biomedicines | 2022 | 35203608 | PubTator, text mining | PubMed |
| Transit Amplifying Progenitors in the Cerebellum: Similarities to and Differences from Transit Amplifying Cells in Other Brain Regions and between Species. | Cells | 2022 | 35203375 | PubTator, text mining | PubMed |
| Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer. | Oncogene | 2022 | 35194152 | PubTator, text mining | PubMed |
| Effects of gestational exposure to bisphenol A on the hepatic transcriptome and lipidome of rat dams: Intergenerational comparison of effects in the offspring. | Sci Total Environ | 2022 | 35192832 | PubTator, text mining | PubMed |
| Glia Regulate the Development, Function, and Plasticity of the Visual System From Retina to Cortex. | Front Neural Circuits | 2022 | 35177968 | PubTator, text mining | PubMed |
| Intragenic suppressors unravel the role of the SCREAM ACT-like domain for bHLH partner selectivity in stomatal development. | Proc Natl Acad Sci U S A | 2022 | 35173013 | PubTator, text mining | PubMed |
| KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer. | Sci Adv | 2022 | 35171684 | PubTator, text mining | PubMed |
| Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma. | Cell Discov | 2022 | 35165277 | PubTator, text mining | PubMed |
| Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer. | Clin Cancer Res | 2022 | 35165102 | PubTator, text mining | PubMed |
| MiR-1226, mediated by ASCL1, suppresses the progression of non-small cell lung cancer by targeting FGF2. | Bull Cancer | 2022 | 35164915 | PubTator, text mining | PubMed |
| c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation. | Cancers (Basel) | 2022 | 35158730 | PubTator, text mining | PubMed |
| Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3. | AIDS | 2022 | 35152224 | PubTator, text mining | PubMed |
| Molecular mechanisms and differences in lynch syndrome developing into colorectal cancer and endometrial cancer based on gene expression, methylation, and mutation analysis. | Cancer Causes Control | 2022 | 35149954 | PubTator, text mining | PubMed |
| ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation. | Sci Rep | 2022 | 35149717 | PubTator, text mining | PubMed |
| Exploration of INSM1 and hASH1 as additional markers in lung cytology samples of high-grade neuroendocrine carcinoma with indeterminate neuroendocrine differentiation. | Diagn Cytopathol | 2022 | 35147301 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=68